MKMuhammet Bugra Karaaslan

Muhammet Bugra Karaaslan

*This is an algorithmically generated author record based on publicly available information.

Muhammet Bugra Karaaslan has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Investigation of the Calcium Metabolism Changes in Rheumatic Mitral Valve Patients

    by Aziz İnan Çelik, Reşit Coşkun, Muhammet Buğra Karaaslan, Tahir Bezgin, Süleyman Karakoyun, Metin Çağdaş

    Introduction: Rheumatic mitral valve disease (RMVD) is associated with autoimmune heart valve injury. Parathyroid hormone (PTH) and vitamin D are two essential molecules that have effects on the immune system. In this study, we aimed to evaluate the relationship between PTH and vitamin D in patients with RMVD. Patients and Methods: We investigated 81 patients with RMVD and 75 healthy subjects. According to Wilkins score, baseline clinical, laboratory, and echocardiographic parameters were recorded, and all RMVD patients were analyzed. Multivariate logistic regression analysis was performed between the groups. Results: Vitamin D levels were significantly low in the RMVD group. Patients were stratified according to Wilkins score [Wilkins scoreConclusion: This study showed that vitamin D levels were low in patients with RMVD. According to the Wilkins score, PTH levels were significantly high in patients with a high Wilkins score. Changes in PTH and vitamin D levels may trigger inflammation and be responsible for valve damage.

  • Open Access

    Hipertansiyona Multidisipliner Yaklaşım-Özlü-Alpay

    by Mehmet Erat, Zakir Lazoğlu, Yasin Bilgin, Ahmet Burak Tatlı, Murat Tuğcu, Okan Akyüz, Murat Gücün, Yeşim Uygun Kızmaz, Tülay Omma, Süleyman Çağan Efe, et al.

    Bu eserimizde; hipertansiyon ile gelen hastalardan yola çıkılarak multidisipliner yaklaşım ile olası patolojiler ve güncel tanı ile tedavi yöntemleri ele alınmaktadır. Hipertansiyona sebep olabilecek patolojiler farklı branşları kapsamakla birlikte çeşitlilik göstermektedir. Hipertansiyon; hem yetişkin hem de çocuklarda kimi zaman bir hastalık belirtisi olurken, kimi zaman da geçici bir durum olabilmektedir. Kan basıncı yükselmesi nedeniyle organları besleyen damarlarda endotelyal disfonksiyon ve inflamatuvar sorunlar gelişmekte, bunun sonucunda da damarın bulunduğu organlarda ölümcül hasarlar oluşabilmektedir. Ailesel yatkınlık hipertansiyona en sık yol açan etken olarak belirtilmektedir. Günlük tuz tüketiminin fazla olması da hipertansiyona neden olan önemli etkenlerden biridir. Aşırı tuzlu beslenmek uzun dönemde hipertansiyona neden olmaktadır. Böbrek hastalıkları tansiyonu yükseltmekte, tansiyon yükseldikçe de böbrekte hasar oluşmaktadır. Bu zinciri kırmanın en önemli noktası ise öncelikle kan basıncını ilaç tedavisiyle kontrol altına almaktır. Kan basıncını yükselten problemlerden biri de çağımızın sorunu olan immobil yaşam ve obezitedir. Hatalı beslenme alışkanlıkları günümüzde hipertansiyonun görülme sıklığında yaşanan artışın en önemli sorunlarından biri diğeridir. Diyabetlilerde hipertansiyon gelişme riski normal popülasyona oranla daha fazladır. Uyku apnesi sorunu olan kişilerde hipertansiyon gelişme riski normal popülasyona göre 2 kat artmaktadır. Stres tek başına etken olmasada hipertansiyona meyil varsa kan basıncı değerini artıran ek bir risk faktörüdür. Sigara kullanımı tansiyonu doğrudan yükseltmese de uzun ve kısa vadede damar endotel disfonksiyonuna neden olmaktadır. Aşırı alkol kullanımı, endojen ve ekzojentoksinlere sekonder karaciğer tahribatı, aşırı yağlanma, gereksiz kalori artışı ve beslenme bozuklukları yaparak hipertansiyonu ikincil etken olarak artırabilen risk faktörleri arasında yer almaktadır. Tiroit hormonları, adrenalin, seratonin ve östrojenlerin yanı sıra böbrek üstü bezinden salgılanan renin, aldosteron ile kortizon gibi hormonların düzensiz ya da fazla salgılanmaları da kan basıncını doğrudan etkilemektedir. Bazı ağrı kesiciler ve hormonal ilaçlar, uzun dönem kullanılan bazı kortizon türevi ilaçlar, yine grip ve nezle için kullanılan bazı ilaçlar da kan basıncında geçici yükselmelere yol açabilmektedir.Bu sebeple de hipertansiyonasebep olan tüm bu patolojilerin geniş açıdan değerlendirilebilmesi için multidisipliner yaklaşım önem taşımaktadır.

  • The importance of heart rate variability in predicting cardiac autonomic dysfunction in patients with amyotrophic lateral sclerosis

    by Dilek İşCan, Muhammet Buğra Karaaslan, Onur Sinan Deveci, Rabia Akıllı Eker, Filiz Koç

    Aim Amyotrophic lateral sclerosis (ALS) is a progressive disease characterized by degeneration in the upper and lower motor neurons of the corticospinal tract, brain stem, and spinal cord. Recent studies have revealed that the disease does not present solely with motor neuron involvement. Accordingly, the aim of this study is to investigate the presence of cardiac autonomic impairment in patients diagnosed with ALS. Material and Method A total of 61 patients, who were diagnosed with ALS according to the Revised El Escorial Criteria (R-EEC), were included in this prospective study, in addition to the 29 healthy individuals, who were included in the study as controls. In order to assess the cardiac autonomic involvement, the presence of orthostatic hypotension was investigated, and transthoracic echocardiography and 24-hour electrocardiogram (ECG) using a Holter monitor were performed. Results Orthostatic hypotension was detected in 14 (22.2%) patients. Holter electrocardiogram results of the patient group revealed statistically significantly lower heart rate variability (HRV) indicators in the time domain (SDNN, SDANN, SDNN index, rMSSD, and pNN50) and in the frequency domain (high frequency [HF], low frequency [LF], and very low frequency [VLF]) than those of the control group (P < .05). Conclusion Contrary to the popular opinion, cardiac autonomic dysfunction in patients with ALS can occur at any stage of the disease. Therefore, it is recommended that the patients are evaluated via periodic examinations during the follow-up period for cardiac autonomic involvement.


  • Open Access

    Role of monocyte to high-density lipoprotein cholesterol ratio in predicting left atrial enlargement in hypertensive patients

    by Aziz Inan Celik, Muhammet Bugra Karaaslan

    OBJECTIVE: Left atrium enlargement is common in hypertension due to left atrium inflammation. Monocyte to high-density lipoprotein cholesterol ratio, an inflammation marker that has become very popular in recent years, is associated with many cardiovascular diseases. The aim of this study is to investigate the monocyte to high-density lipoprotein cholesterol ratio level to predict the Left atrium enlargement in hypertensive patients. METHODS: A total of 216 participants (i.e., 115 hypertensive and 101 control group) were enrolled. Left atrial volumes and left atrial volume indexes were calculated using transthoracic echocardiography. The monocyte to high-density lipoprotein cholesterol ratio was calculated as the ratio of monocyte to high-density lipoprotein cholesterol levels. RESULTS: The left atrial volumes, left atrial volume indexes, and monocyte to high-density lipoprotein cholesterol levels were significantly higher in the hypertensive group than in the control group (43.3 +/- 12.4 versus 31.4 +/- 7.9, p<0.001; 22.9 +/- 5.8 versus 17.1 +/- 3.7, p<0.001; 11.4 [4.2-25.0] versus 8.4 [3.5-18.0], p<0.001, respectively). On the multivariate logistic regression analysis, monocyte to high-density lipoprotein cholesterol ratio (OR 1.38; 95%CI 1.20-1.57; p<0.001), (OR 1.28; 95%CI 1.16-1.42; p<0.001), age, and sex (female) were the independent predictors for hypertension. CONCLUSIONS: The increased monocyte to high-density lipoprotein cholesterol ratio level was associated with hypertension and increased left atrial volume indexes. The results of this study supported the presence of inflammation, measured with a readily available and inexpensive marker, in hypertensive patients and revealed the association with left atrial enlargement.


  • Open Access

    Predictive value of plasma copeptin level for diagnosis and mortality of pulmonary embolism

    by Caglar Ozmen, Onur Sinan Deveci, Muhammet Bugra Karaaslan, Oya Baydar, Anil Akray, Ali Deniz, Caglar Emre Cagliyan, Ismail Hanta, Ayhan Usal

    SUMMARY OBJECTIVE: Early diagnosis and risk stratification may provide a better prognosis in pulmonary embolism (PE). Copeptin has emerged as a valuable predictive biomarker in various cardiovascular diseases. The aim of this study was to determine the levels of copeptin in patients with acute PE and to evaluate its relationship with disease severity and PE-related death. METHODS: Fifty-four patients and 60 healthy individuals were included in this study. Copeptin concentrations and right ventricular dysfunction were analyzed. The correlation between copeptin levels and hemodynamic and echocardiographic parameters was examined. After these first measurements, patients were evaluated with PE-related mortality at the one-year follow-up. RESULTS: The copeptin levels were higher in PE patients than in the control group (8.3 ng/mL vs 3.8 ng/mL, p<0.001). Copeptin levels were found to be significantly higher in patients with PE-related death and right ventricular dysfunction (10.2 vs 7.5 ng/ml, p=0.001; 10.5 vs 7.5 ng/ml, p=0.002, respectively). When the cut-off value of copeptin was ≥5.85, its sensitivity and specificity for predicting PE were 71.9% and 85.0%, respectively (AUC=0.762, 95% CI=0.635-0.889, p<0.001). CONCLUSIONS: The copeptin measurement had moderate sensitivity and specificity in predicting the diagnosis of PE, and the copeptin level was significantly higher in patients with PE-related death at the one-year follow-up. Copeptin may be a useful new biomarker in predicting diagnosis, risk stratification, and prognosis of PE.


  • Open Access

    Determination Of The Effects Of Cryoablation For Atrial Fibrillation On Esophageal Function

    by Muhammet Buğra Karaaslan

    Objective: Periesophageal vagal plexus injury is a complication of cryoablation for atrial fibrillation (AF). The aim of this study is to investigate the effect of cryoablation on esophageal functions and to determine the relationship between esophageal temperature and esophageal motility. Methods: Twenty patients with symptomatic paroxysmal AF who underwent cryoablation were included in this study. The lowest cryoballoon temperature for each pulmonary vein (PV) was recorded. Esophageal temperature was measured using an esophageal probe during each cryoapplication. Esophageal manometry was performed before the procedure and one day after the procedure for each patient in order to assess the esophageal functions. Results: During the procedure, the highest esophageal temperature change was found in the left-side PVs in 13 patients (65%) and in the right-side PVs in seven patients (35%). No correlation was found between the lowest cryoballoon temperature and esophageal temperature change (r=0.22, p=0.05). It was detected that the lower esophageal sphincter pressure and esophageal contraction amplitude pressure decreased after the procedure (before: 19.7 +/- 9.3mm Hg, after: 14.3 +/- 4.9mm Hg, p=0.001; before: 84.5 +/- 28.3 mm Hg, after: 72.7 +/- 34.3mm Hg, p=0.005, respectively). Five patients (25%) developed gastrointestinal symptoms after the procedure. Conclusion: During cryoablation, esophageal temperature measurement can be performed to reduce the probability of esophageal injury. Cryoablation affects esophageal motility, and esophageal manometry can be performed to detect esophageal motility impairments in patients with gastrointestinal symptoms.

  • Open Access

    Predictors of the paroxysmal atrial fibrillation recurrence following cryoballoon-based pulmonary vein isolation: Assessment of left atrial volume, left atrial volume index, galectin-3 level and neutrophil-to-lymphocyte ratio

    by Aziz Inan Celik, Mehmet Kanadasi, Mesut Demir, Ali Deniz, Rabia Eker Akilli, Onur Sinan Deveci, Caglar Emre Cagliyan, Caglar Ozmen, Firat Ikikardes, Muhammet Bugra Karaaslan


  • Open Access

    The Infections of Cardiac Implantable Electronic Devices: Four Year Experience of the Center

    by Ali Deniz, Muhammet Bugra Karaaslan, Aziz Inan Celik, Aslıgul Cureoglu, Hakan Gelincik, Mehmet Kanadasi, Mesut Demir, Ayhan Usal

    Years. The incidence of infection has ranged from 0.5 % to 12% in the literature. The purposes of this study was to investigate the frequency of CIED infection and to find the causes of infection. Patients and methods: Totally, 211 patients with CIED infection were retrospectively evaluated. For each patient, all the following data were recorded; age, sex, CIED type, accompanying diseases, complete blood count, serum biochemistry, echocardiographic findings and whether first implantation or replacement. In addition, wound culture, antibiotic regime, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), glomerular filtration rate (GFR) and anticoagulation test results were recorded in infected patients. Results: CIED infection was detected in 18 of the 211 patients (8.5%). 15 cases developed infection following the first implantation (10%), and 3 cases after replacement (5%). Infection was detected within 60 days in 5 patients. CIED pocket cultures were positive in 12 patients (66.7%). 13 of 18 infected devices were removed (72.2%). Diabetes mellitus [Odds Ratio, OR: 4.56 (1.449-14.408)] (p=0.010), male sex [OR: 3.84 (1.034-14.232)] (p=0.045) and increasing age [OR: 0.96 (0.932-0.998)] (p=0.038) were found as significant independent variables on development of CIED; but, pacemaker, implantable cardioverter defibrillator and cardiac resynchronization were not independent variables [OR: 1.66 (0.469-5.929)] (p=0.43). Conclusions: Increasing age, male sex, diabetes mellitus were related to increased frequency of CIED infections. Identification of comorbid conditions prior to CIED implantations may be important in reducing risk of CIED infections.


  • Evaluation of the Relationship between Dyssynchrony and Myocardial Fibrosis Markers in Patients with Biventricular Pacemaker

    by Vildan Cevher, Rabia Akilli, Muhammet Bugra Karaaslan, Ali Deniz, Mehmet Kanadasi, Ayhan Usal, Mesut Demir